Trial Profile
Randomized, Double Blind, a Phase II/III Clinical Trial to Evaluate the Efficacy and Safety of CJ-50300 in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 16 Jul 2020
Price :
$35
*
At a glance
- Drugs Smallpox vaccine (Primary)
- Indications Smallpox
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 26 Aug 2010 Status changed from recruiting to completed.
- 29 Jun 2010 Results reported in Vaccine.
- 04 Mar 2008 New trial record.